A detailed history of Mendota Financial Group, LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Mendota Financial Group, LLC holds 1 shares of FLGT stock, worth $20. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Holding current value
$20
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$19.6 - $25.06 $19 - $25
1 New
1 $22,000
Q3 2023

Oct 12, 2023

SELL
$26.74 - $40.81 $8,021 - $12,243
-300 Reduced 41.96%
415 $11.1 Million
Q2 2023

Jul 27, 2023

SELL
$28.52 - $40.7 $41,924 - $59,829
-1,470 Reduced 67.28%
715 $26.5 Million
Q1 2023

Apr 24, 2023

BUY
$29.39 - $36.27 $43,203 - $53,316
1,470 Added 205.59%
2,185 $136 Million
Q4 2022

Feb 03, 2023

BUY
$29.23 - $40.28 $20,899 - $28,800
715 New
715 $21.3 Million

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $613M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Mendota Financial Group, LLC Portfolio

Follow Mendota Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mendota Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mendota Financial Group, LLC with notifications on news.